BNP Paribas Exane Has Lowered Expectations for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

Key Points

• BNP Paribas Exane cut its price target on GE HealthCare from $95 to $88, which still implies roughly a 44% upside from the recent close.
• The consensus rating is a Hold (8 Buy / 8 Hold / 1 Sell) with an average analyst target of $82, and several firms including Goldman Sachs, UBS and Barclays have recently lowered ratings or targets.
• GE HealthCare missed Q1 EPS ($0.99 vs. $1.07) but topped revenue estimates ($5.13B), issued FY2026 guidance of $4.80–$5.00 EPS, and saw insider buying by CEO Peter Arduini and other executives.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) had its price target cut by analysts at BNP Paribas Exane from $95.00 to $88.00 in a note issued to investors on Friday,MarketScreener reports. BNP Paribas Exane's price target indicates a potential upside of 44.26% from the stock's previous close.

Several other research firms also recently issued reports on GEHC. Oppenheimer restated an "outperform" rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a report on Thursday. Barclays cut their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an "equal weight" rating on the stock in a report on Thursday. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a report on Saturday, March 21st. UBS Group downgraded GE HealthCare Technologies from a "neutral" rating to a "sell" rating and boosted their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Finally, The Goldman Sachs Group downgraded GE HealthCare Technologies from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $81.00 to $65.00 in a report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $82.00.

GE HealthCare Technologies Price Performance

GEHC stock traded down $0.03 during trading on Friday, hitting $61.00. The company had a trading volume of 7,797,771 shares, compared to its average volume of 4,011,384. The firm has a market capitalization of $27.75 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 1.37 and a beta of 0.75. The business has a 50 day moving average of $73.28 and a 200 day moving average of $77.60. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the firm posted $1.01 earnings per share. GE HealthCare Technologies's revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts predict that GE HealthCare Technologies will post 4.88 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini bought 4,169 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the transaction, the chief executive officer directly owned 259,424 shares of the company's stock, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Frank R. Jimenez bought 1,750 shares of the firm's stock in a transaction on Thursday, April 30th. The shares were bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the transaction, the insider directly owned 93,932 shares of the company's stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 9,229 shares of company stock valued at $556,180 over the last 90 days. 0.36% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. raised its stake in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company's stock worth $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies during the third quarter worth $26,000. Laurel Wealth Advisors LLC acquired a new position in GE HealthCare Technologies during the fourth quarter worth $26,000. Optima Capital LLC acquired a new position in GE HealthCare Technologies during the fourth quarter worth $27,000. Finally, Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth $27,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.